顔用注射剤の市場規模、シェア、動向分析レポート：製品別、用途別、最終用途別、地域別、セグメント別予測、2025年～2030年

顔用注射剤市場の成長と動向

Grand View Research, Inc.の新しいレポートによると、顔用注射剤の世界市場規模は、2025～2030年にかけて12.3％のCAGRを記録し、2030年までに249億米ドルに達する見込みです。

顔用注射剤は、アンチエイジング治療において極めて重要であり、特に色素沈着や早期老化などのダメージを食い止めるために使用されます。すべての社会経済的グループで最も人気のある治療はボトックスとフィラーであり、絶大な人気を得ています。

特に新興諸国における外見重視の開発は、市場を牽引すると予想される主要要因の一つです。加えて、低侵襲処置への消費者の嗜好の変化もまた、市場の成長をサポートすると予想されます。米国形成外科学会（ASPS）によると、2020年に実施された低侵襲手術の上位5つにボツリヌス毒素Aと軟部組織充填剤が入りました。

パンデミックの発生により、2020年の第1四半期と第2四半期には、緊急性のない美容整形手術は保留されました。予防措置として当局機関が厳しい制限を課していたため、コロナウイルスの流行は化粧品産業を含むあらゆる産業に影響を及ぼしています。エステティック関連製品のサプライチェーンも影響を受けた。医療機器セグメント全体の需給チェーンは、パンデミックによって大きく混乱しました。

顔用注射剤市場のレポートハイライト

• 製品タイプ別では、予測期間を通じてA型ボツリヌス毒素セグメントが市場を独占すると予測されます。これは、最も一般的に使用されている低侵襲処置の1つです。
• 用途別では、フェイスライン修正セグメントが市場を独占し、2024年には33.2%の最大収益シェアを占めました。この成長は、フェイスライン、顔のしわ、リップラインなどの美容処置のための顔用注射剤の使用の増加によるものです。
• 最終用途別では、メッドスパ部門が市場を独占し、2024年には47.0%の最大収益シェアを占めました。これらの施設では、経験豊富な専門家による顔用注射、非侵襲的なボディライン、肌の若返り、レーザー治療など、すべての非侵襲的治療が行われています。
• 北米は、製品の入手が容易で、熟練した外科医が多数存在するため、2024年の売上高シェアは38.9%で市場を独占しています。
• アジア太平洋は、主要な収益創出拠点として機能すると予想されます。この地域はインドのような国々に支えられており、外見に対する注目の高まりが市場に有利な機会を生み出すと期待されています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 顔用注射市場の変数、動向、範囲

• 市場系統の展望
  • 親市場の展望
  • 関連/付随市場の展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 顔用注射市場分析ツール
  • 産業分析-ポーターのファイブフォース分析
  • PESTEL分析

第4章 顔用注射剤市場：製品別、推定・動向分析

• 世界の顔用注射剤市場：製品ダッシュボード
• 世界の顔用注射剤市場：製品変動分析
• 世界の顔用注射剤市場（製品別、収益別）
• コラーゲン＆PMMAマイクロスフェア
• ボツリヌス毒素A型
• HA
• CaHA
• PLLA
• その他

第5章 顔用注射剤市場：用途別、推定・動向分析

• 世界の顔用注射剤市場：用途ダッシュボード
• 世界の顔用注射剤市場：用途変動分析
• 用途別収益
• フェイスライン修正
• 唇の増大
• フェイスリフト
• ニキビ跡の治療
• 脂肪萎縮症の治療
• その他

第6章 顔用注射剤市場：最終用途別、推定・動向分析

• 世界の顔用注射剤市場：最終用途ダッシュボード
• 世界の顔用注射剤市場：最終用途変動分析
• 最終用途別収益
• メッドスパ
• 皮膚科クリニック
• 病院
• その他

第7章 顔用注射剤市場：製品、用途、最終用途による地域別、推定・動向分析

• 地域ダッシュボード
• 市場規模、予測動向分析、2018～2030年
• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 企業/競合の分類
  • 主要企業の市場シェア分析（2024年）
  • Ispen
  • Abbvie
  • Medytox Inc.
  • Merz GmbH and Co. KGaA
  • Revance Therapeutics, Inc.
  • Galderma
  • Sinclair Pharma

List of Tables

• Table 1 List of abbreviation
• Table 2 North America Facial Injectable Market, by region, 2018 - 2030 (USD Million)
• Table 3 North America Facial Injectable Market, by product, 2018 - 2030 (USD Million)
• Table 4 North America Facial Injectable Market, by application, 2018 - 2030 (USD Million)
• Table 5 North America Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
• Table 6 U.S. Facial Injectable Market, by product, 2018 - 2030 (USD Million)
• Table 7 U.S. Facial Injectable Market, by application, 2018 - 2030 (USD Million)
• Table 8 U.S. Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
• Table 9 Canada Facial Injectable Market, by product, 2018 - 2030 (USD Million)
• Table 10 Canada Facial Injectable Market, by application, 2018 - 2030 (USD Million)
• Table 11 Canada Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
• Table 12 Europe Facial Injectable Market, by region, 2018 - 2030 (USD Million)
• Table 13 Europe Facial Injectable Market, by product, 2018 - 2030 (USD Million)
• Table 14 Europe Facial Injectable Market, by application, 2018 - 2030 (USD Million)
• Table 15 Europe Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
• Table 16 Germany Facial Injectable Market, by product, 2018 - 2030 (USD Million)
• Table 17 Germany Facial Injectable Market, by application, 2018 - 2030 (USD Million)
• Table 18 Germany Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
• Table 19 UK Facial Injectable Market, by product, 2018 - 2030 (USD Million)
• Table 20 UK Facial Injectable Market, by application, 2018 - 2030 (USD Million)
• Table 21 UK Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
• Table 22 France Facial Injectable Market, by product, 2018 - 2030 (USD Million)
• Table 23 France Facial Injectable Market, by application, 2018 - 2030 (USD Million)
• Table 24 France Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
• Table 25 Italy Facial Injectable Market, by product, 2018 - 2030 (USD Million)
• Table 26 Italy Facial Injectable Market, by application, 2018 - 2030 (USD Million)
• Table 27 Italy Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
• Table 28 Spain Facial Injectable Market, by product, 2018 - 2030 (USD Million)
• Table 29 Spain Facial Injectable Market, by application, 2018 - 2030 (USD Million)
• Table 30 Spain Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
• Table 31 Denmark Facial Injectable Market, by product, 2018 - 2030 (USD Million)
• Table 32 Denmark Facial Injectable Market, by application, 2018 - 2030 (USD Million)
• Table 33 Denmark Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
• Table 34 Sweden Facial Injectable Market, by product, 2018 - 2030 (USD Million)
• Table 35 Sweden Facial Injectable Market, by application, 2018 - 2030 (USD Million)
• Table 36 Sweden Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
• Table 37 Norway Facial Injectable Market, by product, 2018 - 2030 (USD Million)
• Table 38 Norway Facial Injectable Market, by application, 2018 - 2030 (USD Million)
• Table 39 Norway Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
• Table 40 Asia Pacific Facial Injectable Market, by region, 2018 - 2030 (USD Million)
• Table 41 Asia Pacific Facial Injectable Market, by product, 2018 - 2030 (USD Million)
• Table 42 Asia Pacific Facial Injectable Market, by application, 2018 - 2030 (USD Million)
• Table 43 Asia Pacific Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
• Table 44 China Facial Injectable Market, by product, 2018 - 2030 (USD Million)
• Table 45 China Facial Injectable Market, by application, 2018 - 2030 (USD Million)
• Table 46 China Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
• Table 47 Japan Facial Injectable Market, by product, 2018 - 2030 (USD Million)
• Table 48 Japan Facial Injectable Market, by application, 2018 - 2030 (USD Million)
• Table 49 Japan Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
• Table 50 India Facial Injectable Market, by product, 2018 - 2030 (USD Million)
• Table 51 India Facial Injectable Market, by application, 2018 - 2030 (USD Million)
• Table 52 India Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
• Table 53 South Korea Facial Injectable Market, by product, 2018 - 2030 (USD Million)
• Table 54 South Korea Facial Injectable Market, by application, 2018 - 2030 (USD Million)
• Table 55 South Korea Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
• Table 56 Australia Facial Injectable Market, by product, 2018 - 2030 (USD Million)
• Table 57 Australia Facial Injectable Market, by application, 2018 - 2030 (USD Million)
• Table 58 Australia Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
• Table 59 Thailand Facial Injectable Market, by product, 2018 - 2030 (USD Million)
• Table 60 Thailand Facial Injectable Market, by application, 2018 - 2030 (USD Million)
• Table 61 Thailand Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
• Table 62 Latin America Facial Injectable Market, by region, 2018 - 2030 (USD Million)
• Table 63 Latin America Facial Injectable Market, by product, 2018 - 2030 (USD Million)
• Table 64 Latin America Facial Injectable Market, by application, 2018 - 2030 (USD Million)
• Table 65 Latin America Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
• Table 66 Brazil Facial Injectable Market, by product, 2018 - 2030 (USD Million)
• Table 67 Brazil Facial Injectable Market, by application, 2018 - 2030 (USD Million)
• Table 68 Brazil Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
• Table 69 Mexico Facial Injectable Market, by product, 2018 - 2030 (USD Million)
• Table 70 Mexico Facial Injectable Market, by application, 2018 - 2030 (USD Million)
• Table 71 Mexico Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
• Table 72 Argentina Facial Injectable Market, by product, 2018 - 2030 (USD Million)
• Table 73 Argentina Facial Injectable Market, by application, 2018 - 2030 (USD Million)
• Table 74 Argentina Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
• Table 75 MEA Facial Injectable Market, by region, 2018 - 2030 (USD Million)
• Table 76 MEA Facial Injectable Market, by product, 2018 - 2030 (USD Million)
• Table 77 MEA Facial Injectable Market, by application, 2018 - 2030 (USD Million)
• Table 78 MEA Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
• Table 79 South Africa Facial Injectable Market, by product, 2018 - 2030 (USD Million)
• Table 80 South Africa Facial Injectable Market, by application, 2018 - 2030 (USD Million)
• Table 81 South Africa Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
• Table 82 Saudi Arabia Facial Injectable Market, by product, 2018 - 2030 (USD Million)
• Table 83 Saudi Arabia Facial Injectable Market, by application, 2018 - 2030 (USD Million)
• Table 84 Saudi Arabia Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
• Table 85 UAE Facial Injectable Market, by product, 2018 - 2030 (USD Million)
• Table 86 UAE Facial Injectable Market, by application, 2018 - 2030 (USD Million)
• Table 87 UAE Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)
• Table 88 Kuwait Facial Injectable Market, by product, 2018 - 2030 (USD Million)
• Table 89 Kuwait Facial Injectable Market, by application, 2018 - 2030 (USD Million)
• Table 90 Kuwait Facial Injectable Market, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Value-chain-based sizing & forecasting
• Fig. 6 QFD modeling for market share assessment
• Fig. 7 Market formulation & validation
• Fig. 8 Facial Injectable Market: market outlook
• Fig. 9 Facial injectables competitive insights
• Fig. 10 Parent market outlook
• Fig. 11 Related/ancillary market outlook
• Fig. 12 Facial Injectable Market driver impact
• Fig. 13 Facial Injectable Market restraint impact
• Fig. 14 Facial Injectable Market: Product movement analysis
• Fig. 15 Facial Injectable Market: Product outlook and key takeaways
• Fig. 16 Collagen & PMMA microspheres market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 17 Botulinum toxin Type A market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 18 HA market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 19 CaHA market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 20 PLLA market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 21 Others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 22 Facial Injectable Market: Application movement analysis
• Fig. 23 Facial Injectable Market: Application outlook and key takeaways
• Fig. 24 Facial Line Correction market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 25 Lip augmentation market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 26 Face lift market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 27 Acne scar treatment market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 28 Lipoatrophy treatment market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 29 Others market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 30 Facial Injectable Market: End use movement analysis
• Fig. 31 Facial Injectable Market: End use outlook and key takeaways
• Fig. 32 MedSpa market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 33 Dermatology clinics market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 34 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 35 Global Facial Injectable Market: Regional movement analysis
• Fig. 36 Global Facial Injectable Market: Regional outlook and key takeaways
• Fig. 37 Global Facial Injectable Market share and leading players
• Fig. 38 North America, by country
• Fig. 39 North America market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 40 U.S. key country dynamics
• Fig. 41 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 42 Canada key country dynamics
• Fig. 43 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 44 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 45 UK key country dynamics
• Fig. 46 UK market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 47 Germany key country dynamics
• Fig. 48 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 49 France key country dynamics
• Fig. 50 France market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 51 Italy key country dynamics
• Fig. 52 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 53 Spain key country dynamics
• Fig. 54 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 55 Denmark key country dynamics
• Fig. 56 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 57 Sweden key country dynamics
• Fig. 58 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 59 Norway key country dynamics
• Fig. 60 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 61 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 62 China key country dynamics
• Fig. 63 China market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 64 Japan key country dynamics
• Fig. 65 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 66 India key country dynamics
• Fig. 67 India market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 68 Thailand key country dynamics
• Fig. 69 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 70 South Korea key country dynamics
• Fig. 71 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 72 Australia key country dynamics
• Fig. 73 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 74 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 75 Brazil key country dynamics
• Fig. 76 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 77 Mexico key country dynamics
• Fig. 78 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 79 Argentina key country dynamics
• Fig. 80 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 81 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 82 South Africa key country dynamics
• Fig. 83 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 84 Saudi Arabia key country dynamics
• Fig. 85 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 86 UAE key country dynamics
• Fig. 87 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 88 Kuwait key country dynamics
• Fig. 89 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)

Facial Injectable Market Growth & Trends:

The global facial injectable market size is expected to reach USD 24.9 billion by 2030, registering a CAGR of 12.3% from 2025 to 2030, according to a new report by Grand View Research, Inc., The facial injectables are crucial in anti-aging treatments and are particularly used to stop damage such as hyperpigmentation and early aging. The most popular treatments across all socioeconomic groups are Botox and fillers, which have gained immense popularity.

Growing focus on physical appearance, especially in developing countries is one of the key factors expected to drive the market. In addition, a shift in consumer preference towards minimally invasive procedures is also expected to support market growth. According to the American Society of Plastic Surgeons (ASPS), in 2020, botulinum toxin A and soft tissue fillers were among the top 5 minimally invasive procedures carried out in the U.S. Thus, facial injectable holds high growth prospects in the years to come.

The onset of the pandemic led to nonurgent and cosmetic surgeries being put on hold in the first and second quarters of 2020. Since there were stringent restrictions imposed by the authority bodies as a precaution, the coronavirus outbreak has had an impact on every industry, including the cosmetics industry. Aesthetics-related product supply chains were also impacted. The demand-supply chain across the whole medical device sector has been severely disrupted by the pandemic.

Facial Injectable Market Report Highlights:

• Based on product, the botulinum toxin type A segment is projected to dominate the market throughout the forecast period. It is one of the most popularly used minimally invasive procedures
• Based on application, the facial line correction segment dominated the market and accounted for the largest revenue share of 33.2% in 2024. This growth is owing to the increasing use of facial injectables for aesthetic procedures such as facial lines, wrinkles on the face, and lip lines
• Based on end-use, the medSpa segment dominated the market and held the largest revenue share of 47.0% in 2024. All noninvasive treatments are performed in these facilities, which include facial injections, non-invasive body contouring, skin rejuvenation, and laser treatments by experienced professionals
• North America dominated the market with a revenue share of 38.9% in 2024 owing to the easy availability of the products and the presence of a large number of skilled surgeons
• The Asia Pacific region is expected to serve as a key revenue-generating center. The region is backed by countries such as India, where a growing focus on physical appearance is expected to create a lucrative opportunity for the market

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Application
  • 1.2.3. End Use
  • 1.2.4. Regional scope
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Application outlook
  • 2.2.3. End Use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Facial Injectable Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing beauty consciousness among consumers
    • 3.2.1.2. Shift in consumer preference towards minimally invasive procedures
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. High cost of treatment
• 3.3. Facial Injectable Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Facial Injectable Market: Product Estimates & Trend Analysis

• 4.1. Global Facial Injectable Market: Product Dashboard
• 4.2. Global Facial Injectable Market: Product Movement Analysis
• 4.3. Global Facial Injectable Market by Product, Revenue
• 4.4. Collagen & PMMA Microspheres
  • 4.4.1. Collagen & PMMA microspheres market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Botulinum Toxin Type A
  • 4.5.1. Botulinum toxin Type A market estimates and forecasts 2018 to 2030 (USD Million)
• 4.6. HA
  • 4.6.1. HA market estimates and forecasts 2018 to 2030 (USD Million)
• 4.7. CaHA
  • 4.7.1. CaHa market estimates and forecasts 2018 to 2030 (USD Million)
• 4.8. PLLA
  • 4.8.1. PLLA market estimates and forecasts 2018 to 2030 (USD Million)
• 4.9. Others
  • 4.9.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Facial Injectable Market: Application Estimates & Trend Analysis

• 5.1. Global Facial Injectable Market: Application Dashboard
• 5.2. Global Facial Injectable Market: Application Movement Analysis
• 5.3. Global Facial Injectable Market Estimates and Forecasts, By Application, Revenue (USD Million)
• 5.4. Facial Line Correction
  • 5.4.1. Facial line correction market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Lip Augmentation
  • 5.5.1. Lip augmentation market estimates and forecasts 2018 to 2030 (USD Million)
• 5.6. Face Lift
  • 5.6.1. Face lift market estimates and forecasts 2018 to 2030 (USD Million)
• 5.7. Acne Scar Treatment
  • 5.7.1. Acne scar treatment market estimates and forecasts 2018 to 2030 (USD Million)
• 5.8. Lipoatrophy Treatment
  • 5.8.1. Lipoatrophy treatment market estimates and forecasts 2018 to 2030 (USD Million)
• 5.9. Others
  • 5.9.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Facial Injectable Market: End Use Estimates & Trend Analysis

• 6.1. Global Facial Injectable Market: End use Dashboard
• 6.2. Global Facial Injectable Market: End use Movement Analysis
• 6.3. Global Facial Injectable Market Estimates and Forecasts, by End use, Revenue (USD Million)
• 6.4. MedSpa
  • 6.4.1. MedSpa market estimates and forecasts 2018 to 2030 (USD Million)
• 6.5. Dermatology Clinics
  • 6.5.1. Dermatology Clinics market estimates and forecasts 2018 to 2030 (USD Million)
• 6.6. Hospitals
  • 6.6.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
• 6.7. Others
  • 6.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Facial Injectable Market: Regional Estimates & Trend Analysis by Product, Application, and End use

• 7.1. Regional Dashboard
• 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 7.3. North America
  • 7.3.1. U.S.
    • 7.3.1.1. Key country dynamics
    • 7.3.1.2. Regulatory framework/ reimbursement structure
    • 7.3.1.3. Competitive scenario
    • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.2. Canada
    • 7.3.2.1. Key country dynamics
    • 7.3.2.2. Regulatory framework/ reimbursement structure
    • 7.3.2.3. Competitive scenario
    • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
• 7.4. Europe
  • 7.4.1. UK
    • 7.4.1.1. Key country dynamics
    • 7.4.1.2. Regulatory framework/ reimbursement structure
    • 7.4.1.3. Competitive scenario
    • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.2. Germany
    • 7.4.2.1. Key country dynamics
    • 7.4.2.2. Regulatory framework/ reimbursement structure
    • 7.4.2.3. Competitive scenario
    • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.3. France
    • 7.4.3.1. Key country dynamics
    • 7.4.3.2. Regulatory framework/ reimbursement structure
    • 7.4.3.3. Competitive scenario
    • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.4. Italy
    • 7.4.4.1. Key country dynamics
    • 7.4.4.2. Regulatory framework/ reimbursement structure
    • 7.4.4.3. Competitive scenario
    • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.5. Spain
    • 7.4.5.1. Key country dynamics
    • 7.4.5.2. Regulatory framework/ reimbursement structure
    • 7.4.5.3. Competitive scenario
    • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.6. Norway
    • 7.4.6.1. Key country dynamics
    • 7.4.6.2. Regulatory framework/ reimbursement structure
    • 7.4.6.3. Competitive scenario
    • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.7. Sweden
    • 7.4.7.1. Key country dynamics
    • 7.4.7.2. Regulatory framework/ reimbursement structure
    • 7.4.7.3. Competitive scenario
    • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4.8. Denmark
    • 7.4.8.1. Key country dynamics
    • 7.4.8.2. Regulatory framework/ reimbursement structure
    • 7.4.8.3. Competitive scenario
    • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Japan
    • 7.5.1.1. Key country dynamics
    • 7.5.1.2. Regulatory framework/ reimbursement structure
    • 7.5.1.3. Competitive scenario
    • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.2. China
    • 7.5.2.1. Key country dynamics
    • 7.5.2.2. Regulatory framework/ reimbursement structure
    • 7.5.2.3. Competitive scenario
    • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.3. India
    • 7.5.3.1. Key country dynamics
    • 7.5.3.2. Regulatory framework/ reimbursement structure
    • 7.5.3.3. Competitive scenario
    • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.4. Australia
    • 7.5.4.1. Key country dynamics
    • 7.5.4.2. Regulatory framework/ reimbursement structure
    • 7.5.4.3. Competitive scenario
    • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.5. South Korea
    • 7.5.5.1. Key country dynamics
    • 7.5.5.2. Regulatory framework/ reimbursement structure
    • 7.5.5.3. Competitive scenario
    • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5.6. Thailand
    • 7.5.6.1. Key country dynamics
    • 7.5.6.2. Regulatory framework/ reimbursement structure
    • 7.5.6.3. Competitive scenario
    • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 7.6. Latin America
  • 7.6.1. Brazil
    • 7.6.1.1. Key country dynamics
    • 7.6.1.2. Regulatory framework/ reimbursement structure
    • 7.6.1.3. Competitive scenario
    • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.2. Mexico
    • 7.6.2.1. Key country dynamics
    • 7.6.2.2. Regulatory framework/ reimbursement structure
    • 7.6.2.3. Competitive scenario
    • 7.6.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6.3. Argentina
    • 7.6.3.1. Key country dynamics
    • 7.6.3.2. Regulatory framework/ reimbursement structure
    • 7.6.3.3. Competitive scenario
    • 7.6.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
• 7.7. MEA
  • 7.7.1. South Africa
    • 7.7.1.1. Key country dynamics
    • 7.7.1.2. Regulatory framework/ reimbursement structure
    • 7.7.1.3. Competitive scenario
    • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.2. Saudi Arabia
    • 7.7.2.1. Key country dynamics
    • 7.7.2.2. Regulatory framework/ reimbursement structure
    • 7.7.2.3. Competitive scenario
    • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.3. UAE
    • 7.7.3.1. Key country dynamics
    • 7.7.3.2. Regulatory framework/ reimbursement structure
    • 7.7.3.3. Competitive scenario
    • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7.4. Kuwait
    • 7.7.4.1. Key country dynamics
    • 7.7.4.2. Regulatory framework/ reimbursement structure
    • 7.7.4.3. Competitive scenario
    • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Company/Competition Categorization
  • 8.1.1. Key company market share analysis, 2024
  • 8.1.2. Ispen
    • 8.1.2.1. Company overview
    • 8.1.2.2. Financial performance
    • 8.1.2.3. Product benchmarking
    • 8.1.2.4. Strategic initiatives
  • 8.1.3. Abbvie
    • 8.1.3.1. Company overview
    • 8.1.3.2. Financial performance
    • 8.1.3.3. Product benchmarking
    • 8.1.3.4. Strategic initiatives
  • 8.1.4. Medytox Inc.
    • 8.1.4.1. Company overview
    • 8.1.4.2. Financial performance
    • 8.1.4.3. Product benchmarking
    • 8.1.4.4. Strategic initiatives
  • 8.1.5. Merz GmbH and Co. KGaA
    • 8.1.5.1. Company overview
    • 8.1.5.2. Financial performance
    • 8.1.5.3. Product benchmarking
    • 8.1.5.4. Strategic initiatives
  • 8.1.6. Revance Therapeutics, Inc.
    • 8.1.6.1. Company overview
    • 8.1.6.2. Financial performance
    • 8.1.6.3. Product benchmarking
    • 8.1.6.4. Strategic initiatives
  • 8.1.7. Galderma
    • 8.1.7.1. Company overview
    • 8.1.7.2. Financial performance
    • 8.1.7.3. Product benchmarking
    • 8.1.7.4. Strategic initiatives
  • 8.1.8. Sinclair Pharma
    • 8.1.8.1. Company overview
    • 8.1.8.2. Financial performance
    • 8.1.8.3. Product benchmarking
    • 8.1.8.4. Strategic initiatives